SoFi Stock Is Ready to Explode (Here's Why)
1 extracted signal · 0 resolved · 1 still active
The Patient InvestorIndependent analyst profile- Source published
- 03 Aug 2026, 18:10 UTC
- Recorded by Tahlil Plus
- 03 Aug 2026, 19:25 UTC

AI-generated source summary
The analysis focuses on SOFI stock, presenting a bullish outlook based on its valuation and growth prospects. The current share price is $16.31. The projected target price is $39.31, implying a potential upside of 141%. This valuation is derived from a forward P/E ratio of 20, which the analyst considers low given the company's growth potential. The analyst anticipates a target price of $50 for SOFI if it trades at a 25x forward P/E ratio. The company is projected to achieve a 30% CAGR in net revenue and a 42% CAGR in earnings per share between 2025 and 2028. The tangible book value per share is growing at 64.17% year-over-year, reaching $6.70. The stock is currently trading at a tangible book value of $20, which is considered a crucial level. The analyst suggests that if SOFI trades at a 2x tangible book value, its price could reach $40, with a 20.52% implied upside from the current share price. The analyst also notes that SOFI's business model is not a traditional bank, and its ability to generate free cash flow and its strong balance sheet are key supporting factors. The analyst indicates that the stock is undervalued, especially given its long-term growth potential and the possibility of future acquisitions.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Live evaluation in progress
1 signal remains active.
The Patient Investor
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
